Cargando…
Pulmonary fibrosis in patients with COVID-19: A retrospective study
BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic has caused substantial threats to people’s physical health and lives, claiming the lives of over 6 million people worldwide. Although the mortality rate of COVID-19 is very low, many survivors may have different degrees and various sequelae. P...
Autores principales: | Li, Fanglin, Deng, Jiayi, Song, Yongqiang, Wu, Chenfang, Yu, Bo, Wang, Guyi, Li, Jinxiu, Zhong, Yanjun, Liang, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811255/ https://www.ncbi.nlm.nih.gov/pubmed/36619759 http://dx.doi.org/10.3389/fcimb.2022.1013526 |
Ejemplares similares
-
Performance of D-dimer to lymphocyte ratio in predicting the mortality of COVID-19 patients
por: Peng, Fei, et al.
Publicado: (2022) -
The differences in virus shedding time between the Delta variant and original SARS-CoV-2 infected patients
por: Li, Fanglin, et al.
Publicado: (2023) -
The Role of High-Density Lipoprotein in COVID-19
por: Wang, Guyi, et al.
Publicado: (2021) -
Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019) -
Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study
por: Bao, Shujun, et al.
Publicado: (2022)